This menu provides the list of EV proteins identified by high-throughput analyses.

Search:
Superdomain: All Prokaryote Eukaryote
Filter datasets:
  - "Sample type" indicates the source from which EVs originated (e.g. B cell, serum).
  - "Sample status" indicates the condition of the source from which EVs originated (e.g. Normal, miR-146a-treated, Patients of hernia).
Number of molecules in one page:

The downloaded CSV file is not exactly the same as the displayed table. Opening CSV file with Excel can impair its content.

Protein name UniProt accession Publication Orthologous group Identification count
All / Prokaryote / Eukaryote
CD2-associated protein (Adapter protein CMS) (Cas ligand with multiple SH3 domains)Q9Y5K6Isolation and identification of potential urinary microparticle biomarkers of bladder cancer.
J Proteome Res. 2008 May;7(5):2088-96. doi: 10.1021/pr700775x. Epub 2008 Mar 29.		ENOG410XQBY156 / 0 / 156
CD2-associated protein (Adapter protein CMS) (Cas ligand with multiple SH3 domains)Q9Y5K6Large-scale proteomics and phosphoproteomics of urinary exosomes.
J Am Soc Nephrol. 2009 Feb;20(2):363-79. doi: 10.1681/ASN.2008040406. Epub 2008 Dec 3.		ENOG410XQBY156 / 0 / 156
CD2-associated protein (Adapter protein CMS) (Cas ligand with multiple SH3 domains)Q9Y5K6Characterization of PKD protein-positive exosome-like vesicles.
J Am Soc Nephrol. 2009 Feb;20(2):278-88. doi: 10.1681/ASN.2008060564. Epub 2009 Jan 21.		ENOG410XQBY156 / 0 / 156
CD2-associated protein (Adapter protein CMS) (Cas ligand with multiple SH3 domains)Q9Y5K6Proteomic analysis of urine exosomes by multidimensional protein identification technology (MudPIT).
Proteomics. 2012 Jan;12(2):329-38. doi: 10.1002/pmic.201100477. Epub 2011 Dec 16.		ENOG410XQBY156 / 0 / 156
CD2-associated protein (Adapter protein CMS) (Cas ligand with multiple SH3 domains)Q9Y5K6A multiplex quantitative proteomics strategy for protein biomarker studies in urinary exosomes.
Kidney Int. 2012 Jun;81(12):1263-72. doi: 10.1038/ki.2012.25. Epub 2012 Mar 14.		ENOG410XQBY156 / 0 / 156
CD2-associated protein (Adapter protein CMS) (Cas ligand with multiple SH3 domains)Q9Y5K6Proteomic analysis of microvesicles from plasma of healthy donors reveals high individual variability.
J Proteomics. 2012 Jun 27;75(12):3574-84. doi: 10.1016/j.jprot.2012.03.054. Epub 2012 Apr 10.		ENOG410XQBY156 / 0 / 156
CD2-associated protein (Adapter protein CMS) (Cas ligand with multiple SH3 domains)Q9Y5K6Proteomic analysis of microvesicles from plasma of healthy donors reveals high individual variability.
J Proteomics. 2012 Jun 27;75(12):3574-84. doi: 10.1016/j.jprot.2012.03.054. Epub 2012 Apr 10.		ENOG410XQBY156 / 0 / 156
CD2-associated protein (Adapter protein CMS) (Cas ligand with multiple SH3 domains)Q9Y5K6Proteomic analysis of microvesicles from plasma of healthy donors reveals high individual variability.
J Proteomics. 2012 Jun 27;75(12):3574-84. doi: 10.1016/j.jprot.2012.03.054. Epub 2012 Apr 10.		ENOG410XQBY156 / 0 / 156
CD2-associated protein (Adapter protein CMS) (Cas ligand with multiple SH3 domains)Q9Y5K6Biochemical and physical characterisation of urinary nanovesicles following CHAPS treatment.
PLoS One. 2012;7(7):e37279. doi: 10.1371/journal.pone.0037279. Epub 2012 Jul 12.		ENOG410XQBY156 / 0 / 156
CD2-associated protein (Adapter protein CMS) (Cas ligand with multiple SH3 domains)Q9Y5K6Comparative and targeted proteomic analyses of urinary microparticles from bladder cancer and hernia patients.
J Proteome Res. 2012 Dec 7;11(12):5611-29. doi: 10.1021/pr3008732. Epub 2012 Oct 31.		ENOG410XQBY156 / 0 / 156
CD2-associated protein (Adapter protein CMS) (Cas ligand with multiple SH3 domains)Q9Y5K6Comparative and targeted proteomic analyses of urinary microparticles from bladder cancer and hernia patients.
J Proteome Res. 2012 Dec 7;11(12):5611-29. doi: 10.1021/pr3008732. Epub 2012 Oct 31.		ENOG410XQBY156 / 0 / 156
CD2-associated protein (Adapter protein CMS) (Cas ligand with multiple SH3 domains)Q9Y5K6Proteomic analysis of exosomes from mutant KRAS colon cancer cells identifies intercellular transfer of mutant KRAS.
Mol Cell Proteomics. 2013 Feb;12(2):343-55. doi: 10.1074/mcp.M112.022806. Epub 2012 Nov 15.		ENOG410XQBY156 / 0 / 156
CD2-associated protein (Adapter protein CMS) (Cas ligand with multiple SH3 domains)Q9Y5K6Proteomic analysis of exosomes from mutant KRAS colon cancer cells identifies intercellular transfer of mutant KRAS.
Mol Cell Proteomics. 2013 Feb;12(2):343-55. doi: 10.1074/mcp.M112.022806. Epub 2012 Nov 15.		ENOG410XQBY156 / 0 / 156
CD2-associated protein (Adapter protein CMS) (Cas ligand with multiple SH3 domains)Q9Y5K6Proteomic analysis of exosomes from mutant KRAS colon cancer cells identifies intercellular transfer of mutant KRAS.
Mol Cell Proteomics. 2013 Feb;12(2):343-55. doi: 10.1074/mcp.M112.022806. Epub 2012 Nov 15.		ENOG410XQBY156 / 0 / 156
CD2-associated protein (Adapter protein CMS) (Cas ligand with multiple SH3 domains)Q9Y5K6Characterization and proteomic analysis of ovarian cancer-derived exosomes.
J Proteomics. 2013 Jan 16;80C:171-182. doi: 10.1016/j.jprot.2012.12.029.		ENOG410XQBY156 / 0 / 156
CD2-associated protein (Adapter protein CMS) (Cas ligand with multiple SH3 domains)Q9Y5K6Characterization and proteomic analysis of ovarian cancer-derived exosomes.
J Proteomics. 2013 Jan 16;80C:171-182. doi: 10.1016/j.jprot.2012.12.029.		ENOG410XQBY156 / 0 / 156
CD2-associated protein (Adapter protein CMS) (Cas ligand with multiple SH3 domains)Q9Y5K6Proteomic analysis of podocyte exosome-enriched fraction from normal human urine.
J Proteomics. 2013 Apr 26;82:193-229. doi: 10.1016/j.jprot.2013.01.012. Epub 2013 Jan 30.		ENOG410XQBY156 / 0 / 156
CD2-associated protein (Adapter protein CMS) (Cas ligand with multiple SH3 domains)Q9Y5K6Differential protein profiling of renal cell carcinoma urinary exosomes.
Mol Biosyst. 2013 Jun;9(6):1220-33. doi: 10.1039/c3mb25582d. Epub 2013 Mar 19.		ENOG410XQBY156 / 0 / 156
CD2-associated protein (Adapter protein CMS) (Cas ligand with multiple SH3 domains)Q9Y5K6In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine.
Proteomics. 2013 May;13(10-11):1667-71. doi: 10.1002/pmic.201200561. Epub 2013 Apr 23.		ENOG410XQBY156 / 0 / 156
CD2-associated protein (Adapter protein CMS) (Cas ligand with multiple SH3 domains)Q9Y5K6In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine.
Proteomics. 2013 May;13(10-11):1667-71. doi: 10.1002/pmic.201200561. Epub 2013 Apr 23.		ENOG410XQBY156 / 0 / 156
CD2-associated protein (Adapter protein CMS) (Cas ligand with multiple SH3 domains)Q9Y5K6LRRK2 secretion in exosomes is regulated by 14-3-3.
Hum Mol Genet. 2013 Dec 15;22(24):4988-5000. doi: 10.1093/hmg/ddt346. Epub 2013 Jul 25.		ENOG410XQBY156 / 0 / 156
CD2-associated protein (Adapter protein CMS) (Cas ligand with multiple SH3 domains)Q9Y5K6Quantitative proteomics of extracellular vesicles derived from human primary and metastatic colorectal cancer cells.
J Extracell Vesicles. 2012 Sep 11;1. doi: 10.3402/jev.v1i0.18704. eCollection 2012.		ENOG410XQBY156 / 0 / 156
CD2-associated protein (Adapter protein CMS) (Cas ligand with multiple SH3 domains)Q9Y5K6Quantitative proteomics of extracellular vesicles derived from human primary and metastatic colorectal cancer cells.
J Extracell Vesicles. 2012 Sep 11;1. doi: 10.3402/jev.v1i0.18704. eCollection 2012.		ENOG410XQBY156 / 0 / 156
CD2-associated protein (Adapter protein CMS) (Cas ligand with multiple SH3 domains)Q9Y5K6Proteomic profiling of exosomes leads to the identification of novel biomarkers for prostate cancer.
PLoS One. 2013 Dec 31;8(12):e82589. doi: 10.1371/journal.pone.0082589. eCollection 2013.		ENOG410XQBY156 / 0 / 156
CD2-associated protein (Adapter protein CMS) (Cas ligand with multiple SH3 domains)Q9Y5K6Proteomic profiling of exosomes leads to the identification of novel biomarkers for prostate cancer.
PLoS One. 2013 Dec 31;8(12):e82589. doi: 10.1371/journal.pone.0082589. eCollection 2013.		ENOG410XQBY156 / 0 / 156
CD2-associated protein (Adapter protein CMS) (Cas ligand with multiple SH3 domains)Q9Y5K6In-depth proteomic analyses of ovarian cancer cell line exosomes reveals differential enrichment of functional categories compared to the NCI 60 proteome.
Biochem Biophys Res Commun. 2014 Mar 21;445(4):694-701. doi: 10.1016/j.bbrc.2013.12.070. Epub 2014 Jan 14.		ENOG410XQBY156 / 0 / 156
CD2-associated protein (Adapter protein CMS) (Cas ligand with multiple SH3 domains)Q9Y5K6Human urinary exosomes as innate immune effectors.
J Am Soc Nephrol. 2014 Sep;25(9):2017-27. doi: 10.1681/ASN.2013101066. Epub 2014 Apr 3.		ENOG410XQBY156 / 0 / 156
CD2-associated protein (Adapter protein CMS) (Cas ligand with multiple SH3 domains)Q9Y5K6Proteins recruited to exosomes by tau overexpression implicate novel cellular mechanisms linking tau secretion with Alzheimer's disease.
J Alzheimers Dis. 2014;40 Suppl 1:S47-70. doi: 10.3233/JAD-132135.		ENOG410XQBY156 / 0 / 156
CD2-associated protein (Adapter protein CMS) (Cas ligand with multiple SH3 domains)Q9Y5K6Proteomic analysis of cerebrospinal fluid extracellular vesicles: a comprehensive dataset.
J Proteomics. 2014 Jun 25;106:191-204. doi: 10.1016/j.jprot.2014.04.028. Epub 2014 Apr 24.		ENOG410XQBY156 / 0 / 156
CD2-associated protein (Adapter protein CMS) (Cas ligand with multiple SH3 domains)Q9Y5K6Lipidomic and proteomic characterization of platelet extracellular vesicle subfractions from senescent platelets.
Transfusion. 2014 Oct 21. doi: 10.1111/trf.12874.		ENOG410XQBY156 / 0 / 156
CD2-associated protein (Adapter protein CMS) (Cas ligand with multiple SH3 domains)Q9Y5K6A New Workflow for Proteomic Analysis of Urinary Exosomes and Assessment in Cystinuria Patients.
J Proteome Res. 2014 Nov 12.		ENOG410XQBY156 / 0 / 156
CD2-associated protein (Adapter protein CMS) (Cas ligand with multiple SH3 domains)Q9Y5K6Intraluminal proteome and peptidome of human urinary extracellular vesicles.
Proteomics Clin Appl. 2014 Dec 4. doi: 10.1002/prca.201400085.		ENOG410XQBY156 / 0 / 156
CD2-associated protein (Adapter protein CMS) (Cas ligand with multiple SH3 domains)Q9Y5K6Molecular profiling of prostate cancer derived exosomes may reveal a predictive signature for response to docetaxel.
Oncotarget. 2015 Mar 12.		ENOG410XQBY156 / 0 / 156
CD2-associated protein (Adapter protein CMS) (Cas ligand with multiple SH3 domains)Q9Y5K6Molecular profiling of prostate cancer derived exosomes may reveal a predictive signature for response to docetaxel.
Oncotarget. 2015 Mar 12.		ENOG410XQBY156 / 0 / 156
CD2-associated protein (Adapter protein CMS) (Cas ligand with multiple SH3 domains)Q9Y5K6Identification of distinct circulating exosomes in Parkinson's disease.
Ann Clin Transl Neurol. 2015 Apr;2(4):353-61. doi: 10.1002/acn3.175. Epub 2015 Feb 6.		ENOG410XQBY156 / 0 / 156
CD2-associated protein (Adapter protein CMS) (Cas ligand with multiple SH3 domains)Q9Y5K6Proteogenomic analysis reveals exosomes are more oncogenic than ectosomes.
Oncotarget. 2015 Apr 12.		ENOG410XQBY156 / 0 / 156
CD2-associated protein (Adapter protein CMS) (Cas ligand with multiple SH3 domains)Q9Y5K6Proteome characterization of melanoma exosomes reveals a specific signature for metastatic cell lines.
Pigment Cell Melanoma Res. 2015 May 7. doi: 10.1111/pcmr.12380.		ENOG410XQBY156 / 0 / 156
CD2-associated protein (Adapter protein CMS) (Cas ligand with multiple SH3 domains)Q9Y5K6Proteome characterization of melanoma exosomes reveals a specific signature for metastatic cell lines.
Pigment Cell Melanoma Res. 2015 May 7. doi: 10.1111/pcmr.12380.		ENOG410XQBY156 / 0 / 156
CD2-associated protein (Adapter protein CMS) (Cas ligand with multiple SH3 domains)Q9Y5K6Proteome characterization of melanoma exosomes reveals a specific signature for metastatic cell lines.
Pigment Cell Melanoma Res. 2015 May 7. doi: 10.1111/pcmr.12380.		ENOG410XQBY156 / 0 / 156
CD2-associated protein (Adapter protein CMS) (Cas ligand with multiple SH3 domains)Q9Y5K6Proteome characterization of melanoma exosomes reveals a specific signature for metastatic cell lines.
Pigment Cell Melanoma Res. 2015 May 7. doi: 10.1111/pcmr.12380.		ENOG410XQBY156 / 0 / 156
CD2-associated protein (Adapter protein CMS) (Cas ligand with multiple SH3 domains)Q9Y5K6Commitment of Annexin A2 in recruitment of microRNAs into extracellular vesicles.
FEBS Lett. 2015 Nov 26. pii: S0014-5793(15)01049-2. doi: 10.1016/j.febslet.2015.11.036.		ENOG410XQBY156 / 0 / 156
CD2-associated protein (Adapter protein CMS) (Cas ligand with multiple SH3 domains)Q9Y5K6Triple SILAC quantitative proteomic analysis reveals differential abundance of cell signaling proteins between normal and lung cancer-derived exosomes.
J Proteomics. 2015 Dec 28. pii: S1874-3919(15)30222-0. doi: 10.1016/j.jprot.2015.12.023.		ENOG410XQBY156 / 0 / 156
CD2-associated protein (Adapter protein CMS) (Cas ligand with multiple SH3 domains)Q9Y5K6Triple SILAC quantitative proteomic analysis reveals differential abundance of cell signaling proteins between normal and lung cancer-derived exosomes.
J Proteomics. 2015 Dec 28. pii: S1874-3919(15)30222-0. doi: 10.1016/j.jprot.2015.12.023.		ENOG410XQBY156 / 0 / 156
CD2-associated protein (Adapter protein CMS) (Cas ligand with multiple SH3 domains)Q9Y5K6Triple SILAC quantitative proteomic analysis reveals differential abundance of cell signaling proteins between normal and lung cancer-derived exosomes.
J Proteomics. 2015 Dec 28. pii: S1874-3919(15)30222-0. doi: 10.1016/j.jprot.2015.12.023.		ENOG410XQBY156 / 0 / 156
CD2-associated protein (Adapter protein CMS) (Cas ligand with multiple SH3 domains)Q9Y5K6Exosomes mediated pentose phosphate pathway in ovarian cancer metastasis: a proteomics analysis.
Int J Clin Exp Pathol. 2015 Dec 1;8(12):15719-28. eCollection 2015.		ENOG410XQBY156 / 0 / 156
CD2-associated protein (Adapter protein CMS) (Cas ligand with multiple SH3 domains)Q9Y5K6Exosomes mediated pentose phosphate pathway in ovarian cancer metastasis: a proteomics analysis.
Int J Clin Exp Pathol. 2015 Dec 1;8(12):15719-28. eCollection 2015.		ENOG410XQBY156 / 0 / 156
CD2-associated protein (Adapter protein CMS) (Cas ligand with multiple SH3 domains)Q9Y5K6Effective isolation of exosomes with polyethylene glycol from cell culture supernatant for in-depth proteome profiling.
Analyst. 2016 May 27.		ENOG410XQBY156 / 0 / 156
CD2-associated protein (Adapter protein CMS) (Cas ligand with multiple SH3 domains)Q9Y5K6Exosomes in the nose induce immune cell trafficking and harbour an altered protein cargo in chronic airway inflammation.
J Transl Med. 2016 Jun 20;14(1):181. doi: 10.1186/s12967-016-0927-4.		ENOG410XQBY156 / 0 / 156
CD2-associated protein (Adapter protein CMS) (Cas ligand with multiple SH3 domains)Q9Y5K6Proteomic Analysis of Exosomes and Exosome-Free Conditioned Media Derived from Human Osteosarcoma Cell Lines Reveal Differential Secretion of Proteins Related to Biological Functions and Tumor Progression.
J Cell Biochem. 2016 Jun 30. doi: 10.1002/jcb.25642.		ENOG410XQBY156 / 0 / 156
CD2-associated protein (Adapter protein CMS) (Cas ligand with multiple SH3 domains)Q9Y5K6AHNAK enables mammary carcinoma cells to produce extracellular vesicles that increase neighboring fibroblast cell motility.
Oncotarget. 2016 Jun 27. doi: 10.18632/oncotarget.10307.		ENOG410XQBY156 / 0 / 156
CD2-associated protein (Adapter protein CMS) (Cas ligand with multiple SH3 domains)Q9Y5K6Modulation of paracrine signaling by CD9 positive small extracellular vesicles mediates cellular growth of androgen deprived prostate cancer.
Oncotarget. 2016 Aug 8. doi: 10.18632/oncotarget.11111.		ENOG410XQBY156 / 0 / 156
CD2-associated protein (Adapter protein CMS) (Cas ligand with multiple SH3 domains)Q9Y5K6Modulation of paracrine signaling by CD9 positive small extracellular vesicles mediates cellular growth of androgen deprived prostate cancer.
Oncotarget. 2016 Aug 8. doi: 10.18632/oncotarget.11111.		ENOG410XQBY156 / 0 / 156
CD2-associated protein (Adapter protein CMS) (Cas ligand with multiple SH3 domains)Q9Y5K6Efficient production and enhanced tumor delivery of engineered extracellular vesicles.
Biomaterials. 2016 Jul 6;105:195-205. doi: 10.1016/j.biomaterials.2016.07.003.		ENOG410XQBY156 / 0 / 156
CD2-associated protein (Adapter protein CMS) (Cas ligand with multiple SH3 domains)Q9Y5K6Efficient production and enhanced tumor delivery of engineered extracellular vesicles.
Biomaterials. 2016 Jul 6;105:195-205. doi: 10.1016/j.biomaterials.2016.07.003.		ENOG410XQBY156 / 0 / 156
CD2-associated protein (Adapter protein CMS) (Cas ligand with multiple SH3 domains)Q9Y5K6Identification and Characterization of 293T Cell-Derived Exosomes by Profiling the Protein, mRNA and MicroRNA Components.
PLoS One. 2016 Sep 20;11(9):e0163043. doi: 10.1371/journal.pone.0163043. eCollection 2016.		ENOG410XQBY156 / 0 / 156
CD2-associated protein (Adapter protein CMS) (Cas ligand with multiple SH3 domains)Q9Y5K6Proteomic and bioinformatic characterization of extracellular vesicles released from human macrophages upon influenza A virus infection.
J Proteome Res. 2016 Oct 11.		ENOG410XQBY156 / 0 / 156
CD2-associated protein (Adapter protein CMS) (Cas ligand with multiple SH3 domains)Q9Y5K6Proteomic and bioinformatic characterization of extracellular vesicles released from human macrophages upon influenza A virus infection.
J Proteome Res. 2016 Oct 11.		ENOG410XQBY156 / 0 / 156
CD2-associated protein (Adapter protein CMS) (Cas ligand with multiple SH3 domains)Q9Y5K6Extracellular vesicles as a source for non-invasive biomarkers in bladder cancer progression.
Eur J Pharm Sci. 2016 Oct 14. pii: S0928-0987(16)30431-6. doi: 10.1016/j.ejps.2016.10.008.		ENOG410XQBY156 / 0 / 156
CD2-associated protein (Adapter protein CMS) (Cas ligand with multiple SH3 domains)Q9Y5K6Extracellular vesicles as a source for non-invasive biomarkers in bladder cancer progression.
Eur J Pharm Sci. 2016 Oct 14. pii: S0928-0987(16)30431-6. doi: 10.1016/j.ejps.2016.10.008.		ENOG410XQBY156 / 0 / 156
CD2-associated protein (Adapter protein CMS) (Cas ligand with multiple SH3 domains)Q9Y5K6Detailed Analysis of Protein Topology of Extracellular Vesicles-Evidence of Unconventional Membrane Protein Orientation.
Sci Rep. 2016 Nov 8;6:36338. doi: 10.1038/srep36338.		ENOG410XQBY156 / 0 / 156
CD2-associated protein (Adapter protein CMS) (Cas ligand with multiple SH3 domains)Q9Y5K6High-resolution proteomic and lipidomic analysis of exosomes and microvesicles from different cell sources.
J Extracell Vesicles. 2016 Nov 17;5:32570. doi: 10.3402/jev.v5.32570. eCollection 2016.		ENOG410XQBY156 / 0 / 156
CD2-associated protein (Adapter protein CMS) (Cas ligand with multiple SH3 domains)Q9Y5K6High-resolution proteomic and lipidomic analysis of exosomes and microvesicles from different cell sources.
J Extracell Vesicles. 2016 Nov 17;5:32570. doi: 10.3402/jev.v5.32570. eCollection 2016.		ENOG410XQBY156 / 0 / 156
CD2-associated protein (Adapter protein CMS) (Cas ligand with multiple SH3 domains)Q9Y5K6Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.		ENOG410XQBY156 / 0 / 156
CD2-associated protein (Adapter protein CMS) (Cas ligand with multiple SH3 domains)Q9Y5K6Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.		ENOG410XQBY156 / 0 / 156
CD2-associated protein (Adapter protein CMS) (Cas ligand with multiple SH3 domains)Q9Y5K6Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.		ENOG410XQBY156 / 0 / 156
CD2-associated protein (Adapter protein CMS) (Cas ligand with multiple SH3 domains)Q9Y5K6Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.		ENOG410XQBY156 / 0 / 156
CD2-associated protein (Adapter protein CMS) (Cas ligand with multiple SH3 domains)Q9Y5K6Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.		ENOG410XQBY156 / 0 / 156
CD2-associated protein (Adapter protein CMS) (Cas ligand with multiple SH3 domains)Q9Y5K6Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.		ENOG410XQBY156 / 0 / 156
CD2-associated protein (Adapter protein CMS) (Cas ligand with multiple SH3 domains)Q9Y5K6Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.		ENOG410XQBY156 / 0 / 156
CD2-associated protein (Adapter protein CMS) (Cas ligand with multiple SH3 domains)Q9Y5K6Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.		ENOG410XQBY156 / 0 / 156
CD2-associated protein (Adapter protein CMS) (Cas ligand with multiple SH3 domains)Q9Y5K6Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.		ENOG410XQBY156 / 0 / 156
CD2-associated protein (Adapter protein CMS) (Cas ligand with multiple SH3 domains)Q9Y5K6Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.		ENOG410XQBY156 / 0 / 156
CD2-associated protein (Adapter protein CMS) (Cas ligand with multiple SH3 domains)Q9Y5K6Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.		ENOG410XQBY156 / 0 / 156
CD2-associated protein (Adapter protein CMS) (Cas ligand with multiple SH3 domains)Q9Y5K6Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.		ENOG410XQBY156 / 0 / 156
CD2-associated protein (Adapter protein CMS) (Cas ligand with multiple SH3 domains)Q9Y5K6Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.		ENOG410XQBY156 / 0 / 156
CD2-associated protein (Adapter protein CMS) (Cas ligand with multiple SH3 domains)Q9Y5K6Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.		ENOG410XQBY156 / 0 / 156
CD2-associated protein (Adapter protein CMS) (Cas ligand with multiple SH3 domains)Q9Y5K6Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.		ENOG410XQBY156 / 0 / 156
CD2-associated protein (Adapter protein CMS) (Cas ligand with multiple SH3 domains)Q9Y5K6Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.		ENOG410XQBY156 / 0 / 156
CD2-associated protein (Adapter protein CMS) (Cas ligand with multiple SH3 domains)Q9Y5K6Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.		ENOG410XQBY156 / 0 / 156
CD2-associated protein (Adapter protein CMS) (Cas ligand with multiple SH3 domains)Q9Y5K6Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.		ENOG410XQBY156 / 0 / 156
CD2-associated protein (Adapter protein CMS) (Cas ligand with multiple SH3 domains)Q9Y5K6Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.		ENOG410XQBY156 / 0 / 156
CD2-associated protein (Adapter protein CMS) (Cas ligand with multiple SH3 domains)Q9Y5K6Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.		ENOG410XQBY156 / 0 / 156
CD2-associated protein (Adapter protein CMS) (Cas ligand with multiple SH3 domains)Q9Y5K6Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.		ENOG410XQBY156 / 0 / 156
CD2-associated protein (Adapter protein CMS) (Cas ligand with multiple SH3 domains)Q9Y5K6Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.		ENOG410XQBY156 / 0 / 156
CD2-associated protein (Adapter protein CMS) (Cas ligand with multiple SH3 domains)Q9Y5K6Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.		ENOG410XQBY156 / 0 / 156
CD2-associated protein (Adapter protein CMS) (Cas ligand with multiple SH3 domains)Q9Y5K6Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.		ENOG410XQBY156 / 0 / 156
CD2-associated protein (Adapter protein CMS) (Cas ligand with multiple SH3 domains)Q9Y5K6Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.		ENOG410XQBY156 / 0 / 156
CD2-associated protein (Adapter protein CMS) (Cas ligand with multiple SH3 domains)Q9Y5K6Proteomic analysis of urinary extracellular vesicles from high Gleason score prostate cancer.
Sci Rep. 2017 Feb 17;7:42961. doi: 10.1038/srep42961.		ENOG410XQBY156 / 0 / 156
CD2-associated protein (Adapter protein CMS) (Cas ligand with multiple SH3 domains)Q9Y5K6Proteomic analysis of urinary extracellular vesicles from high Gleason score prostate cancer.
Sci Rep. 2017 Feb 17;7:42961. doi: 10.1038/srep42961.		ENOG410XQBY156 / 0 / 156
CD2-associated protein (Adapter protein CMS) (Cas ligand with multiple SH3 domains)Q9Y5K6Proteomic analysis of urinary extracellular vesicles from high Gleason score prostate cancer.
Sci Rep. 2017 Feb 17;7:42961. doi: 10.1038/srep42961.		ENOG410XQBY156 / 0 / 156
CD2-associated protein (Adapter protein CMS) (Cas ligand with multiple SH3 domains)Q9Y5K6Urinary exosomes reveal protein signatures in hypertensive patients with albuminuria.
Oncotarget. 2017 May 11. doi: 10.18632/oncotarget.17787.		ENOG410XQBY156 / 0 / 156
CD2-associated protein (Adapter protein CMS) (Cas ligand with multiple SH3 domains)Q9Y5K6Feasibility of urinary extracellular vesicle proteome profiling using a robust and simple, clinically applicable isolation method.
J Extracell Vesicles. 2017 Apr 28;6(1):1313091. doi: 10.1080/20013078.2017.1313091. eCollection 2017.		ENOG410XQBY156 / 0 / 156
CD2-associated protein (Adapter protein CMS) (Cas ligand with multiple SH3 domains)Q9Y5K6Feasibility of urinary extracellular vesicle proteome profiling using a robust and simple, clinically applicable isolation method.
J Extracell Vesicles. 2017 Apr 28;6(1):1313091. doi: 10.1080/20013078.2017.1313091. eCollection 2017.		ENOG410XQBY156 / 0 / 156
CD2-associated protein (Adapter protein CMS) (Cas ligand with multiple SH3 domains)Q9Y5K6Feasibility of urinary extracellular vesicle proteome profiling using a robust and simple, clinically applicable isolation method.
J Extracell Vesicles. 2017 Apr 28;6(1):1313091. doi: 10.1080/20013078.2017.1313091. eCollection 2017.		ENOG410XQBY156 / 0 / 156
CD2-associated protein (Adapter protein CMS) (Cas ligand with multiple SH3 domains)Q9Y5K6Proteomic analysis of neuroblastoma-derived exosomes: new insights into a metastatic signature.
Proteomics. 2017 Jul 19. doi: 10.1002/pmic.201600430.		ENOG410XQBY156 / 0 / 156
CD2-associated protein (Adapter protein CMS) (Cas ligand with multiple SH3 domains)Q9Y5K6Proteomic analysis of neuroblastoma-derived exosomes: new insights into a metastatic signature.
Proteomics. 2017 Jul 19. doi: 10.1002/pmic.201600430.		ENOG410XQBY156 / 0 / 156
CD2-associated protein (Adapter protein CMS) (Cas ligand with multiple SH3 domains)Q9Y5K6Proteomic analysis of neuroblastoma-derived exosomes: new insights into a metastatic signature.
Proteomics. 2017 Jul 19. doi: 10.1002/pmic.201600430.		ENOG410XQBY156 / 0 / 156
CD2-associated protein (Adapter protein CMS) (Cas ligand with multiple SH3 domains)Q9Y5K6Proteomic analysis of neuroblastoma-derived exosomes: new insights into a metastatic signature.
Proteomics. 2017 Jul 19. doi: 10.1002/pmic.201600430.		ENOG410XQBY156 / 0 / 156
CD2-associated protein (Adapter protein CMS) (Cas ligand with multiple SH3 domains)Q9Y5K6Proteomic analysis of neuroblastoma-derived exosomes: new insights into a metastatic signature.
Proteomics. 2017 Jul 19. doi: 10.1002/pmic.201600430.		ENOG410XQBY156 / 0 / 156
CD2-associated protein (Adapter protein CMS) (Cas ligand with multiple SH3 domains)Q9Y5K6Proteomic analysis of neuroblastoma-derived exosomes: new insights into a metastatic signature.
Proteomics. 2017 Jul 19. doi: 10.1002/pmic.201600430.		ENOG410XQBY156 / 0 / 156
[1] [2]